Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT04340778 Not yet recruiting - Contraception Clinical Trials

Comparative Safety and Efficacy of Vaginal Dinoprostone Versus Lidocaine-prilocaine Cream in Copper IUD Insertion

Start date: April 30, 2020
Phase: Phase 3
Study type: Interventional

the aim of the present study is to Compare Safety and Efficacy of Vaginal dinoprostone Versus Lidocaine-prilocaine Cream in copper IUD Insertion in nulliparous women: a randomized controlled trial

NCT ID: NCT04339361 Not yet recruiting - Contraception Clinical Trials

Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion

Start date: April 25, 2020
Phase: Phase 4
Study type: Interventional

the aim of this study is to compare the safety and Efficacy of Lidocaine Spray Versus Vaginal dinoprostone in relieving pain during levonorgestrel IUD Insertion in nulliparous women

NCT ID: NCT04336865 Not yet recruiting - Contraception Clinical Trials

Effect of Hormonal Contraception on Lower Urinary Tract Symptoms& Sexual Function

Start date: April 15, 2020
Phase:
Study type: Observational

Effect of hormonal contraception on lower urinary tract symptoms& sexual function

NCT ID: NCT04312061 Not yet recruiting - Contraception Clinical Trials

Effect of Oral Tramadol Administration Prior to IUD Insertion

Start date: March 30, 2020
Phase: Phase 3
Study type: Interventional

the aim of the study is to evaluate the safety and efficacy of oral tramadol administration in reducing pain during LNG- IUD insertion in adolescents and young women

NCT ID: NCT04311658 Not yet recruiting - Contraception Clinical Trials

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

Start date: March 30, 2020
Phase: Phase 3
Study type: Interventional

the aim of the study is to evaluate the safety and efficacy of isosorbide mononitrate vaginal administration in reducing pain during LNG-IUD insertion in adolescents and young women

NCT ID: NCT03995043 Not yet recruiting - Pregnancy Related Clinical Trials

Project for Reproductive Equity Through Volunteers and Entrepreneurship, Networks and Technology

PREVENT
Start date: August 2024
Phase: N/A
Study type: Interventional

The PREVENT Project is a multifaceted, adolescent friendly, culturally competent program aimed to address the issues surrounding unplanned pregnancies and lack of access and uptake of contraceptive services among adolescent girls. The intervention uses a mobile platform that provides educational SMS (Short Message Service) messaging, interactive voice response, and connects adolescent girls to community based AFSRH (Adolescent Friendly Sexual Reproductive Health) counselling services, as well as discreet contraceptive access points headed by female entrepreneurs. The program will be piloted for 12 months in various wards and villages in rural and urban Kilimanjaro, Tanzania.The acceptability and practicality of the intervention will be assessed using mixed methods. Questionnaires and focus groups will be conducted with the study participants, as well as the medical and non-medical volunteers at the start and end of the pilot. The study will be heavily supported by all-female non-medical social entrepreneurs and sexual reproductive health community mentors (volunteers), and, all-female medical reproductive health team. Recruitment will also take place in hair saloons (local hair braiding and styling establishments) and other female run business such as tailors and female clothing stores that have enlisted to become contraceptive access points in the study. There will be 2 intervention groups, control and case group. Both groups will receive educational SMS (text) messages on SRH (Sexual Reproductive Health) and access individually tailored educational resources through interactive voice response (IVR) services/system via PREVENT mobile platform. In addition to personal support to be able to contact with a SRH community peer mentor in the community for AFSRH counselling and support. The case group will then have access to contraception provided with detailed and discreet information on accessing PREVENT contraceptive access points in all communities included in the study.

NCT ID: NCT03890705 Not yet recruiting - Contraception Clinical Trials

Postpartum Family Planning Utilization and Associated Factors Among Women During First Year After Childbirth in Assiut

Start date: June 2019
Phase:
Study type: Observational

Postpartum family planning is defined as prevention of unintended pregnancy and closely spaced pregnancies during the first 12 months after the child birth postpartum contraceptive utilization is important because some women resume ovulation after 28 days postpartum inter-pregnancy intervals shorter than 18 to 24 months have been associated with an increased risk of fetal and maternal deaths ,35% of children younger than five deaths could be avoided if births spaced 36 months

NCT ID: NCT03708809 Not yet recruiting - Contraception Clinical Trials

Immediate Versus Delayed Initiation of Intrauterine System

JANESS
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Contraception for teenagers and young adults presents a huge challenge for the clinician as more than half of all unintended pregnancies occur as a result of inconsistent or discontinued use of contraceptives . Possible solution is promoting the use of long acting reversible contraception, (LARC) among them the intrauterine device (IUD). IUD provide safe, highly effective, long-term contraception. Immediate IUD insertion after the termination of pregnancy (TOP) is a very convenient way to provide contraception as it is an opportune moment to carry out this short, easy, and safe procedure. Janess is a T-shaped intrauterine delivery system that was introduced lately, which slowly releases a small amount (13.5 mg) of levonorgestrel after its installation inside the womb and provides contraception for up to three years. The aim of this study to compare insertion of 13.5 mg levonorgestrel-releasing intrauterine system after surgical abortion immediately versus delayed insertion (at menstruation)

NCT ID: NCT03140800 Not yet recruiting - Contraception Clinical Trials

Use Sonography in Patients With Intrauterine Device Presenting With Bleeding

Start date: June 2017
Phase: N/A
Study type: Observational

Intrauterine contraceptive device is one of the most efficient and reversible methods of birth control with low cost and long duration of use However, in the first year after insertion, between 5 and 15% of women will have their Intrauterine contraceptive device removed because of irregular uterine bleeding which have been attributed to the effect of contact between the device and the endometrium and even the pressure on the uterine muscle . The disharmonious relationship between the Intrauterine contraceptive device and the uterus is the cause of most of the bleeding complaints, so bleeding is related to improper position rather than the contraceptive method itself which should be excluded before abandoning the Intrauterine contraceptive device for any other method of birth control